Zoetis Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zoetis Inc's ROI in the second quarter of 2026?
Zoetis Inc achieved a return on average invested assets (ROI) of 19.73 % in its second quarter of 2026, this is above ZTS's average return on investment of 15.33%.
Zoetis Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $13 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of 14.98% from the first quarter of 2026.

Within the Healthcare sector 59 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 314, from total ROI ranking in the first quarter of 2026 at 321.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	15.86 %	9.55 %	1.62 %	-7.46 %	-8.55 %
Y / Y Net Income Change TTM	0.58 %	6.08 %	39.8 %	99.85 %	316.83 %
Investment (TTM) in Millions	13,016	13,101	13,564	13,352	11,295
Return On Investment (TTM)	19.73 %	20.67 %	21.59 %	22.64 %	22.73 %
ZTS's Overall Ranking	# 314	# 321	# 126	# 259	# 226
Seq. Investment Change TTM	3.35 %	4.43 %	5.74 %	1.52 %	-2.28 %
Seq. Net Income Change TTM	-1.32 %	-0.04 %	0.84 %	1.11 %	4.08 %
Net Income (TTM) in Millions	2,616	2,651	2,652	2,630	2,601

ZTS Company Profile >> Back to ZTS Roi Comparisons >> See Annual ZTS Return On Investment

Return On Investment ZTS's Ranking
Within:	No.
Industry	# 30
Sector	# 60
Overall	# 314

Return On Investment Statistics
High	Average	Low
22.37 %	15.33 %	6.18 %
(Jun 30 2025)

News about Zoetis Inc Return on Investment ROI

Zoetis Announces Third Quarter 2024 Results

November 4, 2024

Zoetis Inc.: A Beacon of Growth in Animal Health and Commitment to DiversityAs the global landscape of animal health continues to evolve, Zoetis Inc. (NYSE: ZTS) has been at the forefront, exhibiting remarkable financial growth and an unwavering commitment to Diversity, Equity, and Inclusion (DEandI). With significant strides made in the third quarter of 2024, alongside recognition for its inclusive corporate culture, Zoetis showcases a dual commitment to both economic performance and social responsibility that sets it apart in the animal health industry. Financial Performance Overview In recent announcements, Zoetis reported impressive financial results for the third quarter of 2024. The company achieved revenues of $2.4 billion, marking an 11% increase compared to the same period in the previous year. On an operational basis, the revenue rose even more significantly, with a reported 14% increase year-over-year. This robust financial performance is indicative of Zoetis’ effective strategies in expanding its product offerings and market presence.

Financial Statements
Zoetis Inc's II. Quarter Investments	$ 13,016 Millions	ZTS's Balance sheet
Zoetis Inc's II. Quarter Income	$ 691 Millions	Quarterly ZTS's Income Statement
ZTS's Income by Division		See ZTS's Income by Division

ZTS Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	13,232	10,825	12,391	11,756	12,104
Y / Y Investment Growth	22.24 %	-12.64 %	5.4 %	-2.88 %	5.78 %
Net Income in Millions	2,673	2,496	2,340	2,111	2,034
Y / Y Net Income Growth	7.09 %	6.67 %	10.85 %	3.79 %	24.33 %
Annual Return On Investment	20.2 %	23.06 %	18.88 %	17.96 %	16.8 %

Annual Roi Comment

In the fiscal year 2025 ROI deteriorated to 20.2 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZTS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZTS's Competitors
Subscribers only: Roi for Zoetis Inc's Suppliers
Subscribers only: Return On Investment for ZTS's Customers

Other Ratios
ZTS's Roa	ZTS's Inventory Turnover Ratio	ZTS's Growth Rates	ZTS's Dividend Statistics
	ZTS's Profitability Ratios	ZTS's Asset Turnover Ratio	ZTS's Dividend Growth
ZTS's Roe	ZTS's Valuation Ratios	ZTS's Financial Strength Ratios	ZTS's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Elite Pharmaceuticals Inc	53.48 %
Idexx Laboratories Inc	51.80 %
Aurinia Pharmaceuticals Inc	50.35 %
Qhslab Inc	48.94 %
Q32 Bio Inc	47.43 %
Vaxart Inc	46.17 %
Liquidia Corporation	42.09 %
Tg Therapeutics Inc	39.26 %
Medpace Holdings Inc	35.54 %
Mettler toledo International Inc	34.41 %
Eli Lilly And Company	33.95 %
Acadia Pharmaceuticals Inc	31.05 %
Caredx Inc	29.42 %
Adma Biologics Inc	28.94 %
Protalix Biotherapeutics inc	25.72 %
Pro dex Inc	24.29 %
Innoviva Inc	23.33 %
Electromed Inc	23.18 %
Zevra Therapeutics Inc	22.90 %
Iradimed Corporation	22.57 %
Alnylam Pharmaceuticals Inc	22.10 %
Eton Pharmaceuticals Inc	21.31 %
Dexcom Inc	20.98 %
Healthcare Services Group Inc	20.93 %
Arcutis Biotherapeutics Inc	20.77 %
Chemed Corporation	20.13 %
Resmed Inc	20.01 %
Halozyme Therapeutics Inc	19.99 %
Vertex Pharmaceuticals Inc	19.97 %
Agilent Technologies inc	19.84 %

Date modified: 2026-09-26T07:02:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.